Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Cystoid Macular Edema following cataract surgery
2009-017031-18Phase 4Completed
- Sponsor
- Het Oogziekenhuis Rotterdam
- Start
- Nov 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of nepafenac and prednisolone in cystoid macular edema (CME), sponsored by Het Oogziekenhuis Rotterdam. Primary endpoint: Primary endpoint at 12 weeks. Started Nov 2009; status: completed.
02
Drugs
nepafenacprednisolone
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on 2009-017031-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017031-18.